(RTTNews) - Boston Scientific Corporation (BSX) Monday said it has agreed to acquire medical technology company Cortex, Inc.
Financial terms of the deal have not been disclosed.
Cortex's OptiMap, a diagnostic mapping solution, helps physicians to identify triggers outside of the pulmonary veins that are foundational to atrial fibrillation (AF), a heart rhythm disorder.
"We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases," said Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific.
Boston Scientific expects to complete the transaction in the first half of 2025.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
